[Endometrial cancer associated with an increase of CA 15 3 and CA 125 in tamoxifen treated patients with breast cancer].
The study presents a case of endometrial cancer in a breast cancer patient treated with tamoxifen. The disease occured with elevated values of CA 125 and CA 15_3 tumour markers without any other signs. Additional diagnostic analyses were performed showing a "de novo" endometrial cancer rather than metastatic breast cancer. The patient underwent surgery and radiotherapy. Thereafter, the values of tumour markers were in the reference values.
Sluzba za onkologiju i hematologiju, Kantonalna bolnica Zenica, Zenica, Bosna i Hercegovina. dralmaa@hotmail.com
Alma
A
Mekić-Abazović
Hakija
H
Beculić
Miralem
M
Musić
Almir
A
Fajkić
Senad
S
Dervisević
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000601:surgery; D018394:CA-125 Antigen / Q000032:analysis*; D018270:Carcinoma, Ductal, Breast / Q000188:drug therapy* / Q000601:surgery; D016889:Endometrial Neoplasms / Q000175:diagnosis* / Q000601:surgery; D005260:Female; D006801:Humans; D008875:Middle Aged; D018396:Mucin-1 / Q000032:analysis*; D016609:Neoplasms, Second Primary / Q000175:diagnosis*; D013629:Tamoxifen / Q000627:therapeutic use*
D018931:Antineoplastic Agents, Hormonal; D018394:CA-125 Antigen; D018396:Mucin-1; D013629:Tamoxifen